http://jenavalve.com/about/
Founded 2006
CE mark and European availability Sep 2011
Recently interviewed by Piper Sandler (interestingly they also spoke with Conformal Medical and 4C - Np mention of Admedus...)
”The company is working on a TAVR for both aortic stenosis, but more importantly, regurgitation, with more of an emphasis on the latter”.
Clinical trial kicking off atm, potential submission late this year, possible FDA humanitarian device exemption 2021.
Competitor - JenaValve, page-3
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.25 |
Change
0.350(2.94%) |
Mkt cap ! $251.5M | |||
| Open | High | Low | Value | Volume |
| $12.00 | $12.25 | $12.00 | $104.1K | 8.618K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 54 | $12.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.39 | 485 | 1 |
View Market Depth
| Last trade - 10.13am 11/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |